Neurodevelopment, GABA system dysfunction, and schizophrenia

Martin J. Schmidt, Karoly Mirnics

Research output: Contribution to journalReview article

64 Citations (Scopus)

Abstract

The origins of schizophrenia have eluded clinicians and researchers since Kraepelin and Bleuler began documenting their findings. However, large clinical research efforts in recent decades have identified numerous genetic and environmental risk factors for schizophrenia. The combined data strongly support the neurodevelopmental hypothesis of schizophrenia and underscore the importance of the common converging effects of diverse insults. In this review, we discuss the evidence that genetic and environmental risk factors that predispose to schizophrenia disrupt the development and normal functioning of the GABAergic system.

Original languageEnglish (US)
Pages (from-to)190-206
Number of pages17
JournalNeuropsychopharmacology
Volume40
Issue number1
DOIs
StatePublished - Jan 1 2015

Fingerprint

gamma-Aminobutyric Acid
Schizophrenia
Research Personnel
Research

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health

Cite this

Neurodevelopment, GABA system dysfunction, and schizophrenia. / Schmidt, Martin J.; Mirnics, Karoly.

In: Neuropsychopharmacology, Vol. 40, No. 1, 01.01.2015, p. 190-206.

Research output: Contribution to journalReview article

@article{4b5e5565fd92436bafa627993216f5b4,
title = "Neurodevelopment, GABA system dysfunction, and schizophrenia",
abstract = "The origins of schizophrenia have eluded clinicians and researchers since Kraepelin and Bleuler began documenting their findings. However, large clinical research efforts in recent decades have identified numerous genetic and environmental risk factors for schizophrenia. The combined data strongly support the neurodevelopmental hypothesis of schizophrenia and underscore the importance of the common converging effects of diverse insults. In this review, we discuss the evidence that genetic and environmental risk factors that predispose to schizophrenia disrupt the development and normal functioning of the GABAergic system.",
author = "Schmidt, {Martin J.} and Karoly Mirnics",
year = "2015",
month = "1",
day = "1",
doi = "10.1038/npp.2014.95",
language = "English (US)",
volume = "40",
pages = "190--206",
journal = "Neuropsychopharmacology",
issn = "0893-133X",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Neurodevelopment, GABA system dysfunction, and schizophrenia

AU - Schmidt, Martin J.

AU - Mirnics, Karoly

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The origins of schizophrenia have eluded clinicians and researchers since Kraepelin and Bleuler began documenting their findings. However, large clinical research efforts in recent decades have identified numerous genetic and environmental risk factors for schizophrenia. The combined data strongly support the neurodevelopmental hypothesis of schizophrenia and underscore the importance of the common converging effects of diverse insults. In this review, we discuss the evidence that genetic and environmental risk factors that predispose to schizophrenia disrupt the development and normal functioning of the GABAergic system.

AB - The origins of schizophrenia have eluded clinicians and researchers since Kraepelin and Bleuler began documenting their findings. However, large clinical research efforts in recent decades have identified numerous genetic and environmental risk factors for schizophrenia. The combined data strongly support the neurodevelopmental hypothesis of schizophrenia and underscore the importance of the common converging effects of diverse insults. In this review, we discuss the evidence that genetic and environmental risk factors that predispose to schizophrenia disrupt the development and normal functioning of the GABAergic system.

UR - http://www.scopus.com/inward/record.url?scp=84900721647&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900721647&partnerID=8YFLogxK

U2 - 10.1038/npp.2014.95

DO - 10.1038/npp.2014.95

M3 - Review article

C2 - 24759129

AN - SCOPUS:84900721647

VL - 40

SP - 190

EP - 206

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

SN - 0893-133X

IS - 1

ER -